EO
Evolus, Inc.
EOLS · NASDAQ
$7.86 -1.26% (-$0.10)
1M -6.32%
Market Cap $527.5M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$9.1
15.8% upside
Trenutna cena
$7.86
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EOLS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
85 /100
Cheap P/S 1.67x
PEG N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 25.98%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 10.85%
Op. margin 7.33%
FCF margin 6.37%
Quality
21 /100
Poor ROA 13.84%
Asset turnover 1.28x
ROIC 15.57%
Debt
36 /100
Moderate Int. coverage -1.08x
Current ratio 1.70x
Net debt/EBITDA N/A
Stability
64 /100
Moderate Rev. volatility 13.03%
EPS volatility 12.33%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EOLS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David Moatazedi
Employees
353
Headquarters
Newport Beach
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report